These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6858789)

  • 1. Study of platelet aggregation induced by platelet activating factor (PAF) after administration of ticlopidine or aspirin.
    Lecrubier C; Conard J; Horellou MH; Samama M
    Agents Actions; 1983 Feb; 13(1):77-80. PubMed ID: 6858789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F; Vargaftig BB
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation and inhibition by clonidine of PAF-acether-induced human platelet activation.
    Fouque F; Vargaftig BB
    Eur J Pharmacol; 1987 Mar; 135(2):211-8. PubMed ID: 3582495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by ticlopidine of Paf-acether-induced in vitro aggregation of rabbit and human platelets.
    Lalau Keraly C; Delautier D; Delabassee D; Chignard M; Benveniste J
    Thromb Res; 1984 Jun; 34(6):463-71. PubMed ID: 6740569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of ADP to the amplification of primary platelet aggregation by platelet activating factor (PAF): modulatory role of aspirin.
    Lauri D; Cerletti C; de Gaetano G
    Agents Actions; 1986 Mar; 17(5-6):506-11. PubMed ID: 3706054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective platelet aggregation induced by platelet activating factor in myeloproliferative disorders: deficiency of an aspirin-independent mechanism?
    Viero P; Cortelazzo S; Barbui T; de Gaetano G
    Haemostasis; 1986; 16(1):27-33. PubMed ID: 3699584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cyclooxygenase-independent platelet aggregation by low vitamin E concentration.
    Violi F; Pratico D; Ghiselli A; Alessandri C; Iuliano L; Cordova C; Balsano F
    Atherosclerosis; 1990 Jun; 82(3):247-52. PubMed ID: 2115784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets.
    Vargaftig BB; Fouque F; Benveniste J; Odiot J
    Thromb Res; 1982 Nov; 28(4):557-73. PubMed ID: 7164036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interactions of ticlopidine and aspirin in normal subjects.
    Thebault JJ; Blatrix CE; Blanchard JF; Panak EA
    J Int Med Res; 1977; 5(6):405-11. PubMed ID: 590598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of varying doses of aspirin on human platelet activation induced by PAF, collagen and arachidonic acid.
    Taylor ML; Misso NL; Stewart GA; Thompson PJ
    Br J Clin Pharmacol; 1992 Jan; 33(1):25-31. PubMed ID: 1540486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man.
    May JA; Heptinstall S; Cole AT; Hawkey CJ
    Thromb Res; 1997 Oct; 88(2):183-92. PubMed ID: 9361371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diltiazem potentiates the inhibitory effect of aspirin on platelet aggregation.
    Altman R; Scazziota A; Dujovne C
    Clin Pharmacol Ther; 1988 Sep; 44(3):320-5. PubMed ID: 3416553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lack of augmentation by aspirin of inhibition of platelet reactivity by ticlopidine.
    Farrell TP; Hayes KB; Sobel BE; Schneider DJ
    Am J Cardiol; 1999 Mar; 83(5):770-4. PubMed ID: 10080435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The differential effect of aspirin on human platelet activation in aspirin-sensitive asthmatics and normal subjects.
    Taylor ML; Stewart GA; Thompson PJ
    Br J Clin Pharmacol; 1993 Mar; 35(3):227-34. PubMed ID: 8471399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor (PAF-acether): thromboxane-independent synergism with adrenaline on human platelets and recent insights into its mode of action.
    Fouque F; Joseph D; Vargaftig BB
    Agents Actions; 1982 Dec; 12(5-6):720-2. PubMed ID: 7164947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium.
    Cattaneo M; Canciani MT; Mannucci PM
    Thromb Haemost; 1985 Apr; 53(2):221-4. PubMed ID: 3927505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of aspirin, dipyridamole, nifedipine and cavinton which act on platelet aggregation induced by different aggregating agents alone and in combination.
    Akopov SE; Gabrielian ES
    Eur J Clin Pharmacol; 1992; 42(3):257-9. PubMed ID: 1577042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenaline.
    Vanags DM; Rodgers SE; Duncan EM; Lloyd JV; Bochner F
    Br J Pharmacol; 1992 Aug; 106(4):917-23. PubMed ID: 1393289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor.
    Ostermann G; Till U; Thielmann K
    Thromb Res; 1983 Apr; 30(2):127-36. PubMed ID: 6408754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists.
    Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R
    Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.